Clinical Trials Browser

OTHER × Interventional × Pruritus × Clear all

NCT06931119 2025-04-17

Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients

Phase 1 Not yet recruiting

Pruritus

NCT03992664 2025-02-13

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

Phase NA Completed

BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Colonic Neoplasms, Exanthema, Head and Neck Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Photosensitivity Disorders, Pruritus

NCT06688643 2024-11-14

The Impact of Intrathecal Morphine Versus Continuous Epidural Analgesia on Return of Bowel Function in Patients Undergoing Laparoscopic Ileal Conduit

Phase NA Completed

Urinary Bladder Neoplasms, Pruritus, Postoperative Nausea and Vomiting

NCT02646020 2021-05-18

EGFR-TKIs

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Pruritus

NCT03340155 2017-11-13

BioUV2017

Phase NA Unknown

DermatologicLymphoidMyeloid

Eczema, Graft vs Host Disease, Lichen Planus, Lymphoproliferative Disorders, Mastocytosis, Prurigo, Pruritus, Psoriasis, Vitiligo, Lymphoma, T-Cell, Cutaneous

NCT01625455 2017-05-10

Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome

Phase 4 Terminated

7 enrolled 7 charts

Pruritus, Sezary Syndrome

NCT00863395 2014-03-31

CTCL

Phase 1/2 Terminated

DermatologicLymphoid

Pruritus, Lymphoma, T-Cell, Cutaneous